Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study

Journal of Clinical Oncology

Volumn 15, Issue 8, 1997, Pages 2818-2825

  Gläser, Regine ^a   Rass, Knuth ^a   Seiter, Simone ^a   Hauschild, Axel ^a   Christophers, Enno ^a   Tilgen, Wolfgang ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MONOPHENOL MONOOXYGENASE; TUMOR MARKER;

ARTICLE; BASAL CELL CARCINOMA; BLOOD SAMPLING; CANCER GROWTH; CANCER STAGING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; MULTICENTER STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN METASTASIS;

EID: 0342762020     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.8.2818     Document Type: Article

References (30)

1. Mullis KB, Faloona FA: Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155:335-350, 1987
2. Naito H, Kuzumaki N, Uchino J, et al: Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 27:762-765, 1991
3. Moreno JG, Croce CM, Fischer R, et al: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52:6110-6112, 1992
4. Datta YH, Adams PT, Drobyski WR, et al: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994
5. Schlimok G, Riethmüller G: Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow. Semin Cancer Biol 1:207-215, 1990
6. Smith B, Selby P, Southgate J, et al: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229, 1991
7. Hearing VJ, Jimenez M: Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 2:75-85, 1989
8. Battayani Z, Xerri L, Hassoun J, et al: Tyrosinase gene expression in human tissues. Pigment Cell Res 6:400-405, 1993
9. Tobal K, Sherman LS, Foss, AJE, et al: Detection of melanocytes from uveal melanoma in peripheral blood using the polymerasse chain reaction. Invest Ophthalmol Vis Sci 34:2622-2625, 1993
10. Brossart P, Keilholz U. Willhauck M, et al: Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101:887-889, 1993
11. Brossart P; Keilholz U, Scheibenbogen C, et al: Detection of residual tumor cells, in patients with malignant melanoma responding to immunotherapy. J Immunother 15:38-41, 1994
12. Brossart P, Schmier MW, Krüger S, et al: A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55:4065-4068, 1995
13. Battayani Z, Grob, JJ, Xerri L, et al: Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 131:443-447, 1995
14. Foss AJE, Guille MJ, Occleston NL, et al: The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 72:155-159, 1995
15. Hoon DSB, Wang Y, Dale PS, et al: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-2116, 1995
16. Kunter U, Buer J, Probst M, et al: Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88:590-594, 1996
17. Pittman K, Burchill S, Smith B, et al: Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 7:297-301, 1996
18. Mellado B, Colomer D, Castel T, et al: Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis. J Clin Oncol 14:2091-2097, 1996
19. Reinhold U, Lüdtke-Handjery HC, Schnautz S, et al: The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 108:166-169, 1997
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
21. Arcari P, Martinelli R, Salvatore F: The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species. Nucleic Acids Res 12:9179-9189, 1984
22. Garbe C, Büttner P. Bertz J, et al: Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 75:2484-2491, 1995
23. Zetter BR: The cellular basis of site-specific tumor metastasis. N Engl J Med 322:605-612, 1990
24. Kwon BS, Wakulchik M. Haq AK, et al: Sequence analysis of mouse tyrosinase cDNA and the effect of melanotropin on its gene expression. Biochem Biophys Res Commun 153:1301-1309, 1988
25. Hoganson GE, Ledwitz-Rigby F, Davidson RL, et al: Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP. Somat Cell Mol Genet 15:255-263, 1989
26. Naeyaert JM, Eller M, Gordon PR, et al: Pigment content of cultured human melanocytes does not correlate with tyrosinase message level. Br J Dermatol 125:297-303, 1991
27. Eberle J, Krasagakis K, Garbe C, et al: Proliferation and morphology of melanoma cells and benign human melanocytes under varying culture conditions. Melanoma Res 3:107-112, 1993
28. Buzaid AC, Balch CM: Polymerase chain reaction for detection of melanoma in peripheral blood: Too early to assess clinical value. J Natl Cancer Inst 88:569-570, 1996
29. Guo HB, Stoffel-Wagner B, Bierwirth T, et al: Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 31A:924-928, 1995
30. von Schoultz E, Hansson LO, Djureen E, et al: Prognostic value of serum analyses of S-100β protein in malignant melanoma. Melanoma Res 6:133-137, 1996